HHM Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.91K Hold
50
﹤0.01% 660
2026
Q1
$6.39K Hold
50
﹤0.01% 692
2025
Q4
$6.1K Hold
50
﹤0.01% 680
2025
Q3
$5.01K Hold
50
﹤0.01% 722
2025
Q2
$4.15K Hold
50
﹤0.01% 706
2025
Q1
$4.05K Hold
50
﹤0.01% 688
2024
Q4
$4.5K Hold
50
﹤0.01% 690
2024
Q3
$4.94K Hold
50
﹤0.01% 654
2024
Q2
$4.64K Hold
50
﹤0.01% 640
2024
Q1
$4.75K Hold
50
﹤0.01% 628
2023
Q4
$4.46K Sell
50
-51
-50% -$3.79K ﹤0.01% 639
2023
Q3
$7.38K Hold
101
﹤0.01% 565
2023
Q2
$8.4K Hold
101
﹤0.01% 567
2023
Q1
$7.7K Hold
101
﹤0.01% 563
2022
Q4
$8.38K Hold
101
﹤0.01% 475
2022
Q3
$8K Hold
101
﹤0.01% 476
2022
Q2
$8K Hold
101
﹤0.01% 584
2022
Q1
$9K Hold
101
﹤0.01% 554
2021
Q4
$11K Hold
101
﹤0.01% 513
2021
Q3
$13K Hold
101
﹤0.01% 468
2021
Q2
$14K Hold
101
﹤0.01% 449
2021
Q1
$14K Hold
101
﹤0.01% 423
2020
Q4
$14K Hold
101
﹤0.01% 396
2020
Q3
$11K Hold
101
﹤0.01% 384
2020
Q2
$11K Buy
+101
New +$9.95K ﹤0.01% 369

Other funds holding XBI

HHM Wealth Advisors's XBI Position: Q2 2026 in Review

HHM Wealth Advisors held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 50 shares worth $7.91K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

HHM Wealth Advisors first reported a position in XBI in Q2 2020 and has held it in 25 quarters since. The position peaked at $14K in Q2 2021. 293 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • HHM Wealth Advisors held 50 shares of State Street SPDR S&P Biotech ETF worth $7.91K as of Q2 2026.
  • HHM Wealth Advisors left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #660 holding.
  • HHM Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 25 quarters since.
  • HHM Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $14K in Q2 2021.
  • 293 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.